XML 36 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
CURRENT ASSETS    
Cash and cash equivalents $ 7,600 $ 10,174
BioTime shares held as available-for-sale securities, at fair value 760 2,237
Prepaid expenses and other current assets 168 285
Total current assets 8,528 12,696
NONCURRENT ASSETS    
Intangible assets, net 746 988
Equipment and furniture, net 822 688
Deposits 120 75
TOTAL ASSETS 10,216 14,447
CURRENT LIABILITIES    
Amount due to BioTime and affiliates 2,099 2,854
Accounts payable 175 422
Accrued expenses and other current liabilities 1,042 797
Loan payable, current 800 0
Capital lease liability, current 338 202
Total current liabilities 4,454 4,275
LONG-TERM LIABILITIES    
Loan payable, net of deferred financing costs, noncurrent 1,070 0
Capital lease liability, noncurrent 289 310
TOTAL LIABILITIES 5,813 4,585
Commitments and contingencies (Note 9)
STOCKHOLDERS' EQUITY    
Preferred stock, no par value, 5,000 shares authorized; none issued and outstanding 0 0
Common stock, no par value, 50,000 shares authorized; 31,452 and 28,737 shares issued and outstanding at December 31, 2017 and 2016, respectively 59,968 45,818
Accumulated other comprehensive loss on available-for-sale securities (888) (654)
Accumulated deficit (54,677) (35,302)
Total stockholders' equity 4,403 9,862
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 10,216 $ 14,447